Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
about
Anti-inflammatory preconditioning by agonists of adenosine A1 receptorCharacterization of the human brain putative A2B adenosine receptor expressed in Chinese hamster ovary (CHO.A2B4) cellsLipopolysaccharide rapidly modifies adenosine receptor transcripts in murine and human macrophages: role of NF-kappaB in A(2A) adenosine receptor induction.The resurgence of A2B adenosine receptor signalingP2X1 expressed on polymorphonuclear neutrophils and platelets is required for thrombosis in micePharmacological and biochemical characterization of purified A2a adenosine receptors in human platelet membranes by [3H]-CGS 21680 bindingEctonucleotide triphosphate diphosphohydrolase-1 (CD39) mediates resistance to occlusive arterial thrombus formation after vascular injury in mice.P2X(1) receptor inhibition and soluble CD39 administration as novel approaches to widen the cardiovascular therapeutic windowPhysiological implications of adenosine receptor-mediated platelet aggregation.Dimerization of G protein-coupled purinergic receptors: increasing the diversity of purinergic receptor signal responses and receptor functions.Adenosine and blood platelets.Regulation of leukocyte function by adenosine receptors.A2 adenosine receptors and vascular pathologies.Purinoceptors and platelet aggregation.An endogenous A2B adenosine receptor coupled to cyclic AMP generation in human embryonic kidney (HEK 293) cells.A new role for the A2b adenosine receptor in regulating platelet function.ADORA2A;B bind Ade-Rib
P2860
Q21144315-B521CBD9-BE31-42C3-9F14-34D997E15593Q28379337-151EAC53-A981-41F8-BF10-937A39BF2AE1Q30437433-366B6C5A-489C-40B7-8973-92C2C2F28125Q34307284-08741555-77D7-478B-9E81-2E6DC2344AE2Q35230316-C9CC90AE-AD35-469A-88B0-F72DF57AD9F5Q35873630-CB254EF8-C6F8-42D6-AAA7-1BA725116C88Q36071796-57B5655B-5BC6-4DAE-89F3-5CF2B724EB48Q37494937-A6225455-58F6-4C75-A2A9-2F905B89BF17Q37780716-A13561AC-8D9D-4F01-94AF-B7BDF213B02EQ37789040-A71CE429-AD67-4B23-809A-A6A17D8EE98AQ37864112-D3402449-CD1C-4A69-87F2-1FFC484B3E2FQ37876538-5BB284EE-C829-466B-8E73-DB58C9551AF1Q37994174-4AD814C5-2EE7-4C38-BA5B-FF42D747141FQ41456002-D386091A-B233-4E41-8D34-424B06EA145EQ43177455-989F2658-6470-4449-B344-4C997E507829Q43183880-E98D1E47-9D3C-4508-9A5E-862D20F40A8BQ50296909-64951B04-ABFC-45CB-957D-61E558AA0188
P2860
Adenosine receptor-induced cyclic AMP generation and inhibition of 5-hydroxytryptamine release in human platelets.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Adenosine receptor-induced cyc ...... ine release in human platelets
@nl
Adenosine receptor-induced cyc ...... ne release in human platelets.
@ast
Adenosine receptor-induced cyc ...... ne release in human platelets.
@en
type
label
Adenosine receptor-induced cyc ...... ine release in human platelets
@nl
Adenosine receptor-induced cyc ...... ne release in human platelets.
@ast
Adenosine receptor-induced cyc ...... ne release in human platelets.
@en
prefLabel
Adenosine receptor-induced cyc ...... ine release in human platelets
@nl
Adenosine receptor-induced cyc ...... ne release in human platelets.
@ast
Adenosine receptor-induced cyc ...... ne release in human platelets.
@en
P2093
P2860
P1476
Adenosine receptor-induced cyc ...... ne release in human platelets.
@en
P2093
P2860
P356
10.1111/J.1365-2125.1995.TB04533.X
P407
P577
1995-07-01T00:00:00Z